TY  - CHAP
M1  - Book, Section
TI  - Chapter 41. The Critically Ill Poisoned Patient
A1  - Hoffman, Robert J.
A2  - Farcy, David A.
A2  - Chiu, William C.
A2  - Flaxman, Alex
A2  - Marshall, John P.
PY  - 2012
T2  - Critical Care Emergency Medicine
AB  - The  2001  publication  by  the  American  Heart  Association,  TOX-ACLS  Toxicologic-Oriented  Advanced  Life  Support,1  marked  wide  recognition  that  critical  illness  resulting  from  poisoning  may  require  very  different  management  from  similar  illness  occurring  in  the  nonpoisoned  patient.  That  publication  made  specific  suggestions  for  management  of  dysrhythmias  and  other  toxicity  caused  by  cocaine,  calcium  channel  blockers  and  β-blockers,  opioids,  tricyclic  antidepressants,  and  drug-induced  cardiovascular  shock.  In  2010,  the  updated  American  Heart  Association  ACLS  guidelines  contained  specific  evaluation  and  recommendations  regarding  poisoning  with  these  same  aforementioned  toxins,  as  well  as  cyanide,  digoxin,  and  antidotal  therapy  with  flumazenil  and  lipid  emulsion.2  The  relevance  of  those  publications  is  recognition  that  proper  management  of  many  clinical  problems  caused  by  toxins  differs  or  deviates  from  management  of  the  same  clinical  problem  occurring  in  the  nonpoisoned  patient.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/19
UR  - accessemergencymedicine.mhmedical.com/content.aspx?aid=55814823
ER  -